Levofloxacin in TB Treatment Regimens

Introduction to Levofloxacin Use

The World Health Organization recommends levofloxacin as part of the standard 6-month regimen for patients with confirmed rifampicin-susceptible, isoniazid-resistant TB, consisting of rifampicin, ethambutol, pyrazinamide, and levofloxacin 1, 2, 3
This represents a conditional WHO recommendation based on evidence showing improved treatment success when fluoroquinolones are added (adjusted OR: 2.8, 95% CI: 1.1-7.3) 2

Levofloxacin or moxifloxacin should be included in longer MDR/RR-TB regimens (strong recommendation, moderate certainty of evidence) 1, 3
Levofloxacin is classified as a Group A priority drug—the highest priority category—for building MDR-TB regimens 4
All three Group A agents (levofloxacin/moxifloxacin, bedaquiline, and linezolid) should be included to ensure at least four effective drugs are used 1, 3, 4

Standard adult dose: 500-1,000 mg daily 5
Levofloxacin is generally preferred over moxifloxacin due to fewer adverse events and less QTc prolongation 4

A large observational study found that only 4.0% of patients on levofloxacin required permanent discontinuation due to adverse events 6
Gastrointestinal disturbance (nausea, bloating): 0.5-1.8% 5
Neurologic effects (dizziness, insomnia, tremulousness, headache): 0.5% 5
Cutaneous reactions (rash, pruritus, photosensitivity): 0.2-0.4% 5

Critical: Do not administer levofloxacin within 2 hours of antacids or medications containing divalent cations (calcium, magnesium, aluminum, iron), as these markedly decrease fluoroquinolone absorption 5, 7, 8

Avoid fluoroquinolones in pregnancy due to teratogenic effects 5
Use cautiously in children and adolescents due to concerns about effects on bone and cartilage growth, though most experts agree levofloxacin should be considered for pediatric MDR-TB 5
Avoid empirical fluoroquinolone use in patients with suspected TB as it may delay diagnosis and increase fluoroquinolone resistance risk 9

Dosage adjustment to 750-1,000 mg three times weekly is recommended if creatinine clearance <50 mL/minute 5
For end-stage renal disease or hemodialysis: administer 50% of normal dose every 48 hours after hemodialysis 8

Drug levels are not affected by hepatic disease 5
Presumed safe in severe liver disease, though use with caution as with all drugs 5

Always separate levofloxacin from antacids, multivitamins, or calcium supplements by at least 2 hours to prevent malabsorption 5, 7, 8
Monitor for overlapping gastrointestinal symptoms that could be attributed to either levofloxacin or other TB medications 7
Evaluate any new symptoms during TB treatment for drug toxicity rather than automatically attributing them to over-the-counter medications 7
Persistent cough after 3 months of treatment may indicate treatment failure rather than inadequate symptom control, especially if sputum cultures remain positive 7

Cross-resistance exists among ciprofloxacin, ofloxacin, and levofloxacin and is presumed to be a class effect 5